0LI: 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzam
ide
0LI is a Ligand Of Interest in 6EG9 designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6EG9_0LI_A_501 | 61% | 9% | 0.16 | 0.949 | 2.75 | 1.74 | 11 | 8 | 0 | 0 | 100% | 1 |
| 6EG9_0LI_B_501 | 60% | 9% | 0.177 | 0.962 | 2.73 | 1.78 | 11 | 13 | 2 | 0 | 100% | 1 |
| 6P3D_0LI_A_1001 | 88% | 16% | 0.098 | 0.973 | 2.03 | 1.66 | 6 | 11 | 0 | 0 | 100% | 1 |
| 7WF5_0LI_A_601 | 84% | 26% | 0.085 | 0.948 | 1.54 | 1.46 | 7 | 5 | 1 | 0 | 100% | 1 |
| 4U0I_0LI_A_1001 | 83% | 15% | 0.103 | 0.96 | 2.57 | 1.26 | 18 | 5 | 2 | 0 | 100% | 1 |
| 6TU9_0LI_A_801 | 82% | 74% | 0.11 | 0.965 | 0.31 | 0.69 | - | 1 | 1 | 0 | 100% | 1 |
| 3ZOS_0LI_A_1000 | 82% | 31% | 0.087 | 0.941 | 1.37 | 1.38 | 4 | 6 | 0 | 0 | 100% | 1 |
